Exosome Blood-Based Biomarker Discovery

September 20, 2013 Leave a comment

Eli Lilly Enters Collaboration Agreement with Exosome Diagnostics NEW YORK September 19, 2013 — Exosome Diagnostics today announced it has entered into a collaboration agreement with Eli Lilly and Company (NYSE: LLY) for biomarker discovery and validation using Exosome Diagnostics ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: EXO50

Exosome Blood-Based Biomarker Discovery

Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines

Extracellular vesicles from the placenta may offer major clues on the in utero development of neurobehavioral disorders

Exai Bio’s RNA- and AI-based Liquid Biopsy Platform Detects Early Stage Breast Cancer with High Accuracy, Overcoming Many Limitations of DNA-based Approaches

HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment

NVIGEN unveils groundbreaking comprehensive liquid biopsy – multimodal biomarker detection enabled by highly versatile nanoparticle capture

SEVtras delineates small extracellular vesicles at droplet resolution from single-cell transcriptomes